BBP

Virtus Biotech ETF

Investor Moves

NameValueActionChangePriceCurrent Price
Ken GriffinCitadel Advisors
$-1.0M
ExitQ4 2025
$1.0M
--
--
Ken GriffinCitadel Advisors
$-1.0M
ExitQ4 2025
$1.0M
--
--
Ken GriffinCitadel Advisors
$631.8K
AddQ3 2025
$632k
--
--
Ken GriffinCitadel Advisors
$631.8K
AddQ3 2025
$632k
--
--
Ken GriffinCitadel Advisors
$-300.9K
TrimQ2 2025
$301k
--
--
Ken GriffinCitadel Advisors
$-300.9K
TrimQ2 2025
$301k
--
--

News

globenewswire.comBridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9globenewswire.comMay 27globenewswire.comBridgeBio Submits NDA to FDA for BBP-418 for Individuals Living with LGMD2I/R9globenewswire.comMar 30
BBP smart money exposure | 交易笔记